glutathione bromopyruvic acid reaction Anticancer agent 3-bromopyruvic forms a conjugate with | Pharmacological Reports Frontiers | 3-Bromopyruvate as an
Frontiers 3 Bromopyruvate as an Alternative Option for the Treatment of Protothecosis Anticancer agent 3 bromopyruvic acid forms a conjugate with glutathione ScienceDirect Phase II Glutathione Conjugation Metabolism of Herbicides or Xenobiotics in Plants passel Reaction schemes of nucleophilic substitution of the thiolate anion of Download Scientific Diagram The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect Drug metabolizing enzymes and their inhibitors' role in cancer resistance ScienceDirect
Pay in 4 interest-free payments of $6.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




